Marcus Schlemmer

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma.

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma.

Journal: Cureus

Published: May 28, 2019

Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.

Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.

Journal: Oncology research and treatment

Published: December 19, 2018

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.

Journal: Clinical genitourinary cancer

Published: November 08, 2017

Redefining diagnosis-related groups (DRGs) for palliative care - a cross-sectional study in two German centres.

Redefining diagnosis-related groups (DRGs) for palliative care - a cross-sectional study in two German centres.

Journal: BMC palliative care

Published: March 31, 2017

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Journal: JAMA oncology

Published: March 24, 2017

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 04, 2015

Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.

Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.

Journal: European radiology

Published: October 26, 2015

Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?

Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: August 05, 2014

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.

Journal: Cancer

Published: December 21, 2013

Rational imaging of metastasized tumor diseases

Rational imaging of metastasized tumor diseases

Journal: Der Internist

Published: June 06, 2013

Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.

Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.

Journal: European journal of radiology

Published: August 18, 2012

Adjuvant therapy in primary GIST: state-of-the-art.

Adjuvant therapy in primary GIST: state-of-the-art.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 27, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026